Research

Characterising the retina and subsequent damage in a model of Mucopolysaccharidosis Type IIIC

Characterisation of Retinal Phenotype in HGSNAT-deficient mice (Mucopolysaccharidosis Type IIIC)

Developing a Patient Reported Outcome Measure (PROM) for inflammatory eye disease and validation of a novel approach for PROM content identification

Novel cell therapy approach to reduce IOP in glaucoma via nitric oxide production

Characterisation of retinal development in a zebrafish model of Wolfram Syndrome

Addressing Barriers to Amblyopia Therapy

Inflammatory eye disease as a Canary in the Coal Mine for future autoimmune disease: combining genetic and other variables to enhance individual risk prediction

Developing a new model to study drusen formation

Modelling drusen formation in retinal pigment epithelial cells and investigating drug candidates to slow the progression of AMD.

Understanding a molecular mechanism as a cause of retinitis pigmentosa

Exploring the molecular mechanism of a new cause of autosomal dominant retinitis pigmentosa and potential therapies.

Optogenetic therapy with CRISPR-assisted activation of rhodopsin